IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 16.825
NA - Nord America 3.323
EU - Europa 1.745
SA - Sud America 69
AF - Africa 58
OC - Oceania 52
AN - Antartide 1
Totale 22.073
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 12.947
US - Stati Uniti d'America 3.166
CN - Cina 1.794
HK - Hong Kong 1.781
GB - Regno Unito 570
IT - Italia 447
DE - Germania 222
IN - India 120
NL - Olanda 114
CA - Canada 112
FI - Finlandia 64
JP - Giappone 54
UA - Ucraina 49
ZA - Sudafrica 49
AU - Australia 48
BR - Brasile 45
TR - Turchia 45
MX - Messico 41
PL - Polonia 41
FR - Francia 34
ES - Italia 33
SE - Svezia 26
EE - Estonia 23
CZ - Repubblica Ceca 22
CH - Svizzera 18
BE - Belgio 15
ID - Indonesia 15
AT - Austria 13
LT - Lituania 11
KR - Corea 10
RU - Federazione Russa 9
SA - Arabia Saudita 8
BD - Bangladesh 7
PE - Perù 7
TW - Taiwan 7
AR - Argentina 6
CL - Cile 6
UZ - Uzbekistan 5
VN - Vietnam 5
PT - Portogallo 4
RO - Romania 4
SI - Slovenia 4
EG - Egitto 3
IE - Irlanda 3
IL - Israele 3
IR - Iran 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DM - Dominica 2
FK - Isole Falkland (Malvinas) 2
GH - Ghana 2
GR - Grecia 2
HU - Ungheria 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TJ - Tagikistan 2
AM - Armenia 1
AQ - Antartide 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LV - Lettonia 1
MS - Montserrat 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
SL - Sierra Leone 1
SN - Senegal 1
SR - Suriname 1
TL - Timor Orientale 1
TO - Tonga 1
TV - Tuvalu 1
YE - Yemen 1
Totale 22.073
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.754
Hefei 1.088
Singapore 1.049
Ashburn 787
Boardman 656
London 504
Shanghai 352
Beijing 195
Los Angeles 147
San Francisco 120
Council Bluffs 117
Munich 101
Rome 85
Amsterdam 77
Pune 77
Seattle 68
Toronto 67
Santa Clara 58
Washington 54
New York 46
Warsaw 41
Turku 39
Tokyo 35
Brooklyn 31
Johannesburg 31
São Paulo 31
Mexico City 28
Milan 28
Chicago 26
Helsinki 25
Boston 24
Melbourne 23
Stockholm 23
Dallas 22
Brno 20
Montreal 20
Chennai 19
Secaucus 18
St Louis 17
The Dalles 14
Charlotte 13
Sydney 13
Ankara 12
Canberra 12
Central 12
Hasselt 12
Naples 12
West Jordan 12
Atlanta 9
Hanover 9
Palermo 9
Phoenix 9
Bologna 8
Modena 8
Sona 8
Vienna 8
Denver 7
Frankfurt am Main 7
Haikou 7
Manchester 7
Turin 7
Campobasso 6
Guangzhou 6
Lima 6
Mong Kok 6
Mumbai 6
New Delhi 6
Padova 6
Redmond 6
Riyadh 6
Bari 5
Ekimaedori 5
Hangzhou 5
New Taipei 5
Novara 5
Paris 5
Poplar 5
San Pietro in Lama 5
Teramo 5
Topeka 5
Yeonsu-gu 5
Andover 4
Cascina 4
Casole d'Elsa 4
Charleston 4
Gennevilliers 4
Helena 4
Honolulu 4
Istanbul 4
Las Vegas 4
Liverpool 4
Mantova 4
Marcellina 4
Markham 4
Miami 4
Monza 4
Nagoya 4
Nanjing 4
Parma 4
San Jose 4
Totale 8.303
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 293
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 222
Cardiotossicità da antracicline 214
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 211
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 208
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 203
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 203
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 203
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 201
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 197
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 196
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 195
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 195
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 194
Premetastatic niche: ready for new therapeutic interventions? 192
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 192
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 192
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 191
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 187
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 187
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 186
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 185
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 184
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 184
Prevention of radiotherapy-induced emesis 183
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 181
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 181
Urinary complications from breast cancer metastasis: case report and review of the literature 181
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 180
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 180
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 179
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 179
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 177
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 174
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 172
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 171
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 171
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 170
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 169
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 167
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 167
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 166
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 162
Docetaxel induced pericardial effusion 161
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 154
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 139
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 125
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 110
A giant sarcoma of the parotid gland: A case report and review of the literature 109
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 109
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 106
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 105
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 102
An international survey on the use of guidelines for palliative sedation therapy 101
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 98
'Old' and 'new' drugs for the treatment of cancer pain 98
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 97
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 96
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 95
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 95
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 93
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 92
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 91
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 90
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 90
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 90
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 89
Idiosyncratic reaction after oxaliplatin infusion 89
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 89
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 89
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 89
Biological effects of cabozantinib on bone microenvironment 89
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 89
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 89
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 88
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 88
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 88
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 87
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 87
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 87
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 86
Azygo-tracheal fistula in a complete implantable central venous system 86
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 86
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 86
Atypical chronic head and neck pain: don't forget Eagle's syndrome 86
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 84
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 84
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 84
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 82
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 82
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 80
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 78
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 77
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 77
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 76
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 72
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 69
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 65
Classic Kaposi Sarcoma: to treat or not to treat? 65
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 63
Totale 13.376
Salva come PNG Salva come JPEG
Categoria #
all - tutte 200.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022754 0 9 12 4 49 12 10 9 24 23 26 576
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.890 49 213 155 165 158 766 27 113 27 53 81 83
2024/202517.411 277 217 720 138 146 421 296 76 1.523 1.325 5.825 6.447
2025/20261.996 1.509 487 0 0 0 0 0 0 0 0 0 0
Totale 22.245